Lv1
100 积分 2024-07-05 加入
Pharmacotherapy for the Treatment of Gastric Antral Vascular Ectasia: A Narrative Review
28天前
已关闭
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia
1个月前
已完结
ApoC-III as Therapeutic Target: Is it Primetime for Clinical Use?
1个月前
已完结
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
1个月前
已完结
Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia
1个月前
已完结
Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia
1个月前
已完结
Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk
2个月前
已完结
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk
2个月前
已完结
Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
2个月前
已完结